Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus

Background: New-onset diabetes mellitus after transplantation (NODAT) is a well-known complication of transplantation. Objective: To determine the correlation between CMV infection and NODAT. Methods: Retrospectively, we detected CMV replication (PCR) in every month after renal transplantation in the first 12 months of the procedure in a homogenous group of patients from the immunosuppression point of view. Results: In 167 patients (64 with NODAT and 103 in the control group), the average amount of CMV viremia was not significantly different between the NODAT and the control group (p=0.929). In the 10th month of transplantation, we recorded a significantly higher CMV viremia in the NODAT group (p<0.0001), however, in the multivariant analysis, the observed statistical difference vanished. The survival of patients and grafts was 12 months after kidney transplantation without any statistically significant difference between the studied groups (p=0.611 and p=0.538, respectively). Conclusion: CMV is not a risk factor for NODAT.

[1]  P. Galajda,et al.  Waist circumference as an independent risk factor for NODAT. , 2015, Annals of transplantation.

[2]  M. Salesi,et al.  The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: a review on current findings , 2014, Journal of nephropathology.

[3]  N. Inoue,et al.  The presence of antibodies against the AD2 epitope of cytomegalovirus glycoprotein B is associated with acute rejection after renal transplantation , 2014, Microbiology and immunology.

[4]  H. Rollag,et al.  The impact of early cytomegalovirus infection after kidney transplantation on long‐term graft and patient survival , 2014, Clinical transplantation.

[5]  S. Pham,et al.  New onset diabetes after transplantation (NODAT): an overview , 2011, Diabetes, metabolic syndrome and obesity : targets and therapy.

[6]  S. Goh,et al.  Incidence and risk factors for development of new-onset diabetes after kidney transplantation. , 2011, Annals of the Academy of Medicine, Singapore.

[7]  D. Janczak,et al.  The increased risk of post-transplant diabetes mellitus in peritoneal dialysis-treated kidney allograft recipients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  H. Hirsch,et al.  Viral impact on long-term kidney graft function. , 2010, Infectious disease clinics of North America.

[9]  Ethan M Balk,et al.  KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.

[10]  B. Einollahi,et al.  Cytomegalovirus disease in renal transplant recipients: an Iranian experience. , 2008, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[11]  V. Kliem,et al.  Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial. , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  H. Rollag,et al.  Reduced Incidence of New-Onset Posttransplantation Diabetes Mellitus During the Last Decade , 2007, Transplantation.

[13]  A. Webster,et al.  Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. , 2007, The Cochrane database of systematic reviews.

[14]  Yi-Shan Chen,et al.  Post-transplant Diabetes Mellitus in Renal Transplant Recipients-Experience in Buddhist Tzu Chi General Hospital , 2006 .

[15]  A. Hartmann,et al.  The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. , 2006, Kidney international.

[16]  T. Habuchi,et al.  Clinical and Genetic Risk Factors for Posttransplant Diabetes Mellitus in Adult Renal Transplant Recipients Treated with Tacrolimus , 2005, Transplantation.

[17]  H. Rollag,et al.  Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced β-cell damage , 2005 .

[18]  S. Puumala,et al.  New-Onset Diabetes after Kidney Transplantation: An Application of 2003 International Guidelines , 2005, Transplantation.

[19]  M. Schnitzler,et al.  Guidelines for the treatment and management of new‐onset diabetes after transplantation 1 , 2005, Clinical transplantation.

[20]  J. Fishman,et al.  Viral infection in the renal transplant recipient. , 2005, Journal of the American Society of Nephrology : JASN.

[21]  M. Kessler,et al.  Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. , 2005, Transplantation proceedings.

[22]  P. Koskinen,et al.  Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  T. Egeland,et al.  Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation , 2004, Diabetologia.

[24]  G. Opelz,et al.  Cytomegalovirus Prophylaxis and Graft Outcome in Solid Organ Transplantation: A Collaborative Transplant Study Report , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Y. Lebranchu,et al.  Induction therapy by anti‐thymocyte globulin (rabbit) in renal transplantation: a 1‐yr follow‐up of safety and efficacy , 2003, Clinical transplantation.

[26]  F. Cosio,et al.  Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. , 2002, Kidney international.

[27]  S. Gabriel,et al.  Posttransplantation diabetes: a systematic review of the literature. , 2002, Diabetes care.

[28]  B. Alexander,et al.  Viral infections after renal transplantation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  D. Brennan.  Cytomegalovirus in renal transplantation. , 2001, Journal of the American Society of Nephrology : JASN.

[30]  T. Egeland,et al.  Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. , 1997, Transplantation.

[31]  R. Rubin.  Infectious disease complications of renal transplantation. , 1993, Kidney international.

[32]  T. Schwab,et al.  Management and prevention of cytomegalovirus infection after renal transplantation. , 1992, Mayo Clinic proceedings.

[33]  J. Breza,et al.  Vascular complications after renal transplantation. , 2010, Bratislavske lekarske listy.

[34]  J. Craig,et al.  Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. , 2006, Transplantation.

[35]  A. Webster,et al.  Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. , 2005, The Cochrane database of systematic reviews.

[36]  M. Stegall,et al.  PROSPECTIVE, RANDOMIZED TRIAL OF THE EFFECT OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION: THREE-YEAR RESULTS1 , 2004, Transplantation.

[37]  B. Kasiske,et al.  NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES , 2003 .